patient compliance
See the following -
Going Mobile: How Mobile Technology is Evolving in Clinical Trials
...[M]obile communication has been leveraged to provide information and access to services across multiple industries, from simple applications such as checking train timetables to mobile banking with secure access to personal information in a highly regulated industry. Clinical research is no exception to this trend and indeed the pharmaceutical industry has seen an increasing movement to leverage mobile technology to engage with patients and collect their data during clinical trials...
- Login to post comments
OpenClinica’s Enterprise EDC Selected to Drive Clinical Trials Research Pharmacist (CTRP) Service
OpenClinica, a provider of cloud-based electronic data capture (EDC) for clinical research, announced today that Center Point Clinical Services has selected OpenClinica to support their team of licensed pharmacists in the counseling of clinical trial patients. Known as Clinical Trials Research Pharmacists (or CTRPs), Center Point's pharmacists reinforce trial requirements for patients, helping to ensure proper dosing and storage of trial drugs and providing one-on-one, 24/7 patient counseling on concomitant medications, medical device use, dietary and lifestyle issues, as well as answer questions or concerns patients have about the trial. Read More »
- Login to post comments
StayWell Adds SMART on FHIR App to Krames CareEngage Solution, Increasing Integration Capabilities Across Care Systems
The StayWell Company announced today that Krames CareEngageTM powered by Doctella now features a SMART on FHIR application. The SMART on FHIR application is available for testing with clients who use CareEngage for patient education and care management. StayWell will demonstrate the CareEngage solution during #HiMSS17 at booth 3443. CareEngage is an interactive platform that addresses real-world health needs, such as patient compliance and chronic conditions, by keeping patients better informed and engaged in their care...
- Login to post comments